These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31626178)

  • 1. [The effectiveness and feasibility of preventive interventions for psychoses].
    Dorofeikova MV; Petrova NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(8):108-112. PubMed ID: 31626178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic interventions in prodromal psychosis: safety issues.
    Liu CC; Demjaha A
    CNS Drugs; 2013 Mar; 27(3):197-205. PubMed ID: 23436256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is clinical intervention in the ultra high risk phase effective?
    McGuire P; Selvaraj S; Howes O
    Braz J Psychiatry; 2011 Oct; 33 Suppl 2():s161-74. PubMed ID: 22286566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research in people with psychosis risk syndrome: a review of the current evidence and future directions.
    Correll CU; Hauser M; Auther AM; Cornblatt BA
    J Child Psychol Psychiatry; 2010 Apr; 51(4):390-431. PubMed ID: 20214698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-Year Follow-up of Cognitive Behavioral Therapy in Persons at Ultra-High Risk for Developing Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.
    Ising HK; Kraan TC; Rietdijk J; Dragt S; Klaassen RM; Boonstra N; Nieman DH; Willebrands-Mendrik M; van den Berg DP; Linszen DH; Wunderink L; Veling W; Smit F; van der Gaag M
    Schizophr Bull; 2016 Sep; 42(5):1243-52. PubMed ID: 26994397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research and practice for ultra-high risk for psychosis: A national survey of early intervention in psychosis services in England.
    Stain HJ; Mawn L; Common S; Pilton M; Thompson A
    Early Interv Psychiatry; 2019 Feb; 13(1):47-52. PubMed ID: 28612979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis.
    Wijnen BFM; Thielen FW; Konings S; Feenstra T; Van Der Gaag M; Veling W; De Haan L; Ising H; Hiligsmann M; Evers SMAA; Smit F; Lokkerbol J
    Expert Rev Pharmacoecon Outcomes Res; 2020 Jun; 20(3):269-279. PubMed ID: 31195900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis.
    Nieman DH; Rike WH; Becker HE; Dingemans PM; van Amelsvoort TA; de Haan L; van der Gaag M; Denys DA; Linszen DH
    Int Clin Psychopharmacol; 2009 Jul; 24(4):223-8. PubMed ID: 19521246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EPA guidance on the early detection of clinical high risk states of psychoses.
    Schultze-Lutter F; Michel C; Schmidt SJ; Schimmelmann BG; Maric NP; Salokangas RK; Riecher-Rössler A; van der Gaag M; Nordentoft M; Raballo A; Meneghelli A; Marshall M; Morrison A; Ruhrmann S; Klosterkötter J
    Eur Psychiatry; 2015 Mar; 30(3):405-16. PubMed ID: 25735810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-centre randomized controlled trial.
    Ising HK; Smit F; Veling W; Rietdijk J; Dragt S; Klaassen RM; Savelsberg NS; Boonstra N; Nieman DH; Linszen DH; Wunderink L; van der Gaag M
    Psychol Med; 2015 May; 45(7):1435-46. PubMed ID: 25330734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness.
    Preti A; Cella M
    Schizophr Res; 2010 Oct; 123(1):30-6. PubMed ID: 20727717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early onset psychosis: rationale and concept of a cognitive-behavioral intervention].
    Güttgemanns J; Büch A; Sevecke K; Döpfner M; Lehmkuhl G; Herrlich J; Müller K; Wiedemann G; Klingberg S; Bechdolf A
    Fortschr Neurol Psychiatr; 2011 Sep; 79(9):524-30. PubMed ID: 21870313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges of assessment and treatment of ultra high risk for psychosis in an adolescent.
    Boričević Maršanić V; Jukić J; Flander M
    Psychiatr Danub; 2018 Jun; 30(Suppl 4):166-168. PubMed ID: 29864753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
    Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
    Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants.
    O'Donoghue B; Francey SM; Nelson B; Ratheesh A; Allott K; Graham J; Baldwin L; Alvarez-Jimenez M; Thompson A; Fornito A; Polari A; Berk M; Macneil C; Crisp K; Pantelis C; Yuen HP; Harrigan S; McGorry P
    Early Interv Psychiatry; 2019 Aug; 13(4):953-960. PubMed ID: 30024100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal patterns of social functioning and conversion to psychosis in subjects at ultra-high risk.
    Jang JH; Shin NY; Shim G; Park HY; Kim E; Jang GE; Kwon SJ; Hur JW; An SK; Kwon JS
    Aust N Z J Psychiatry; 2011 Sep; 45(9):763-70. PubMed ID: 21827349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy and clinical characteristics of ultra-high-risk for psychosis according to conversion status: a naturalistic observational study.
    Kim E; Jang JH; Park HY; Shim G; Hwang JY; Kim SN; Kwon JS
    Early Interv Psychiatry; 2012 Feb; 6(1):30-7. PubMed ID: 22029630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.